Daniel Sop, MS, PhD
Daniel Sop is a distinguished figure in the field of Biomedical Engineering, heralded for his remarkable contributions to the intersection of technology, healthcare, and research. With over 15 years of technical and computational expertise and more than a decade of dedicated involvement in healthcare data management, Sop stands as a trailblazer in his field. As a driven biomedical engineer, research scientist, and Doctoral candidate, his journey has been marked by an unwavering commitment to advancing medical science and patient care.
Born with a curiosity for unraveling complex problems, Daniel embarked on his academic journey at Old Dominion University in Norfolk, Virginia, where he earned a Bachelor of Science degree. This academic foundation laid the groundwork for his illustrious career. However, it was his pursuit of a Master of Science in Biomedical Engineering from Virginia Commonwealth University in Richmond, Virginia, that truly catapulted him into the heart of cutting-edge research and innovation.
At present, Daniel is diligently finishing his doctoral degree in Biomedical Engineering at Virginia Commonwealth University, where his focus centers on the development of objective pain measurement methodologies. His passion for enhancing pain assessment methods stems from his desire to alleviate the suffering experienced by patients, particularly those afflicted with sickle cell disease. This dedication led him to a prominent role as the Senior Research Scientist within the Division of General Internal Medicine at Virginia Commonwealth University, where he spearheads various government and privately funded grants dedicated to advancing the understanding and treatment of sickle cell disease. Additionally, Daniel has been working in the field of neuroscience where he uses magnetic resonance imaging to explore and expose the impact that Sickle Cell Disease has on brain hemodynamics for patients and the downstream role it plays on their pain perception and cognitive functioning.
Notably, Daniel's brilliance was recognized nationally when he was selected as one of only nine to participate in and successfully complete the prestigious DC I-Corps program in 2016. This program, designed to expedite technology transfer and catalyze the growth of technology-based startups, showcased his adeptness at bridging the gap between academia and real-world applications. His drive to create meaningful impact did not stop there, as he continued to excel in developing mobile-based applications for pain monitoring in sickle cell patients. This groundbreaking initiative forms an ongoing project that aims to unravel patterns of pain and opioids utilization, thereby providing crucial insights for both clinicians and patients.
Daniel's journey of excellence recently culminated in his selection as a fellow by the Pittsburgh Intensive Training in Hematology Research (PITHR), an esteemed NIH research education program. This recognition underscores his commitment to fostering diversity in the biomedical research workforce while advancing our understanding of hematology and its intricate interplay with pain.
At the core of Daniel's work lies an unyielding aspiration: the development of a validated, objective pain measurement tool that could revolutionize pain-related diagnostics, opioid usage, and the doctor-patient relationship. His current research delves into evaluating the hemodynamic parameters of the brain and fluid cognition in response to different pharmacotherapies, exemplifying his prowess in synthesizing clinical insights with advanced technological methodologies.
In Daniel Sop, the world of biomedical engineering finds a luminary who envisions a future unburdened by pain-related misdiagnoses and opioid-related challenges. His unflagging pursuit of excellence, compassionate approach to patient care, and innovative research endeavors position him as a beacon of hope and progress in the realm of medical science. As he continues to push the boundaries of what is possible, Daniel Sop leaves an indelible mark on the field and an inspiring legacy for future generations to emulate.
​
